The global automated liquid handling market size was valued at USD 1.39 billion in 2025 and is projected to grow from USD 1.50 billion in 2026 to USD 2.77 billion by 2034, registering a CAGR of 7.98% during the forecast period from 2026 to 2034. North America dominated the automated liquid handling market with a market share of 39.2% in 2025.
Automated liquid handling (ALH) systems are carefully programmed to handle liquids and provide precise, repeatable results in clinical and research settings without any complexity. A wide variety of research applications require effective and precise liquid handling methods. Liquid handling quality must be carefully considered for outcomes to be reliable and consistent. High throughput is highly anticipated in these processes because the diagnostics industry bases profits and productivity on the number of processed samples.
Download a Free Sample To learn more about this report,
AI-Driven Adaptive Liquid Handling
The need for higher experimental throughput, reproducibility, and adaptive protocols is driving AI-enabled liquid handling, shifting systems from fixed pipetting instructions toward platforms that optimize dispensing and experimental parameters using real-time data; the automated liquid handling market analysis shows that a 2025 autonomous laboratory study used Bayesian optimization with a liquid handler and other instruments to create a closed loop from culturing and analysis to hypothesis generation.
Self-Driving Laboratory Integration
Autonomous experimentation is also moving liquid handlers into self-driving laboratory workflows, where robotic systems execute AI-selected experiments and feed results into subsequent experimental cycles; a 2025 Nature Communications review describes these laboratories as combining digital experiment planning with automated physical hardware to adapt workflows and optimize research.
Increasing Laboratory Workload and Sample Volumes and the Need to Reduce Manual Pipetting Errors Drive Market
Rising sample volumes across pharmaceutical, biotechnology, and clinical laboratories increase demand for automated liquid handling systems that can process large batches efficiently. Higher testing requirements in genomics, drug screening, and clinical diagnostics place greater pressure on laboratories to improve throughput without expanding manual workloads. Applications such as automated PCR sample preparation and high-throughput compound screening demonstrate the need for rapid and consistent liquid transfers. Growing laboratory workloads encourage investment in multi-channel pipetting systems, automated workstations, and high-throughput platforms. The resulting equipment demand supports market expansion as laboratories seek greater processing capacity and operational efficiency.
Frequent manual pipetting creates risks of volume inconsistencies, contamination, and operator-related errors, increasing demand for automated systems that provide precise and repeatable liquid transfers. Stringent reproducibility requirements in PCR testing, cell-based assays, and pharmaceutical research make accurate dispensing essential for reliable experimental results. Applications such as automated reagent dispensing during PCR setup help maintain consistent volumes across large batches of samples. Greater emphasis on laboratory accuracy encourages organizations to replace repetitive manual processes with automated pipetting platforms. This shift increases demand for precision liquid handlers and supports suppliers offering reliable, application-specific automation solutions.
High Initial Investment and Setup Costs and Limited Flexibility for Highly Customized Workflows Restrain Market Expansion
Advanced automated liquid handling systems require significant spending on equipment, software, installation, validation, and laboratory infrastructure upgrades. The high upfront financial burden is particularly challenging for small and medium-sized laboratories with limited capital budgets. This can delay automation decisions and slow adoption across cost-sensitive laboratories.
Laboratories with specialized assays, frequently changing protocols, or low-volume processes may find standardized automation platforms difficult to adapt. Extensive customization can require additional programming, hardware modifications, and integration support, increasing system complexity and operating costs. These limitations can discourage adoption among research laboratories with diverse workflows and constrain market expansion.
Expansion of Automated Liquid Handling in Biopharmaceutical Manufacturing and Integration with Laboratory Information Management Systems Offer Growth Opportunities
Biopharma production facilities can adopt automated liquid-handling equipment for buffer preparation, reagent dispensing, and formulation activities. Hamilton Company and Tecan serve this space, giving manufacturers opportunities to earn from specialized instruments, application-specific configurations, and after-sales services.
Laboratories can link liquid-handling platforms with LIMS to strengthen sample tracking, result management, and regulatory documentation. Thermo Fisher Scientific and LabWare offer laboratory informatics capabilities, creating revenue potential through software connectivity, data-management modules, and integration services.
Integration with Existing Laboratory Infrastructure and Software and Data-Management Complexity Hinders Growth
Integrating automated liquid handlers with legacy instruments, laboratory information management systems (LIMS), and other automation platforms can create compatibility and data-transfer issues. For example, laboratories using mixed equipment from different vendors often require additional interface development, which slows automation deployment and limits adoption.
Managing increasingly sophisticated control software, protocols, instrument data, and connectivity requirements can create operational bottlenecks for laboratories. Poor interoperability between automation software and laboratory systems can reduce workflow efficiency and make companies more cautious about expanding automated liquid-handling deployments.
The individual benchtop workstation accounted for a share of 35.6% in 2025 due to its compact design, ease of integration into existing laboratory workflows, and suitability for routine liquid-handling tasks. Its flexibility in handling varying sample volumes and protocols also makes it suitable for research laboratories, clinical settings, and small-scale testing environments.
The multi-instrument system segment is expected to grow at a CAGR of 12.38%, driven by increasing demand for integrated laboratory platforms that can automate multiple liquid-handling and sample-processing functions. Its ability to connect multiple instruments within a single workflow improves throughput, reduces manual intervention, and supports complex high-volume laboratory operations. The standalone segment continues to see demand due to its straightforward setup, independent operation, and suitability for laboratories with specific automation requirements.
Request Customizationto receive a tailored report.
The drug discovery & ADME-Tox Research segment accounted for a share of 36.9% in 2025 due to the growing need for high-throughput screening, accurate sample preparation, and automated compound testing in pharmaceutical research. Increasing drug development activity and the need to improve research efficiency while reducing manual errors further support the adoption of automated liquid handling systems in this segment.
The cancer & genomic research segment is expected to grow at a CAGR of 12.56%, driven by increasing genomic studies, molecular diagnostics, and cancer research requiring precise and high-throughput sample processing. Growing adoption of next-generation sequencing and other genomic workflows is increasing the need for automated liquid handling to improve reproducibility and processing efficiency. The bioprocessing/biotechnology segment is supported by the growing use of automated liquid handling in cell culture, assay preparation, and biopharmaceutical development.
The disposable tip segment accounted for a share of 63.8% in 2025 due to its ability to minimize cross-contamination risks, eliminate tip washing requirements, and support reliable sample handling in high-throughput laboratories. Its suitability for sensitive applications such as molecular diagnostics, drug discovery, and genomics further strengthens adoption among laboratories seeking consistent and contamination-controlled workflows.
The fixed tip segment is expected to grow at a CAGR of 9.64%, driven by its reusability and suitability for laboratories performing repetitive liquid-handling procedures. Its lower recurring consumable requirements and compatibility with routine workflows support continued demand where cost efficiency and repeated use are important.
The high-throughput screening accounted for a share of 23.7% in 2025 due to its widespread use in drug discovery and pharmaceutical research, where automated systems enable rapid processing of large numbers of samples with high accuracy and consistency. Growing demand for faster compound screening, reproducible assay results, and efficient handling of large sample volumes further supports the adoption of automated liquid handling systems in this procedure.
The whole genome amplification segment is expected to grow at a CAGR of 12.08%, driven by increasing demand for comprehensive genomic analysis from limited DNA samples. Its use in single-cell analysis, genetic research, and molecular diagnostics is increasing the need for precise and automated sample preparation. The PCR setup segment is supported by the growing use of PCR-based testing in molecular diagnostics, genetic research, and infectious disease detection.
The serial dilution segment benefits from its widespread use in pharmaceutical testing, microbiology, and assay preparation. Automation enables accurate and repeatable dilution across multiple samples, reducing manual errors and improving laboratory efficiency. The cell culture segment is driven by increasing use of cell-based assays in drug discovery, biotechnology, and biomedical research.
The plate reformatting segment is supported by the growing need to transfer samples between different microplate formats in high-throughput laboratory workflows. Automation improves transfer accuracy and speeds up sample preparation, helping laboratories manage large numbers of samples efficiently. The array printing segment is gaining adoption in genomic, proteomic, and diagnostic research that requires precise deposition of biological samples onto array surfaces.
The biotechnology and pharmaceutical companies accounted for a share of 52.4% in 2025 due to the extensive use of automated liquid handling systems in drug discovery, formulation research, screening, and biopharmaceutical development. High sample volumes and the need for precise, reproducible laboratory workflows further drive adoption across these companies.
The contract research organizations (CROs) segment is expected to grow at a CAGR of 12.41%, driven by increasing outsourcing of drug discovery, clinical research, and laboratory testing activities by pharmaceutical and biotechnology companies. The academic and government research institutes segment is supported by increasing research activities in genomics, molecular biology, drug development, and life sciences. Greater emphasis on high-throughput experimentation and reproducible research is increasing the use of automated liquid handling systems across research laboratories.
Speak to an Analystto discuss market opportunities.
The North America automated liquid handling market accounted for the largest regional share of 39.2% in 2025, driven by the region’s advanced laboratory infrastructure, high adoption of automation technologies, and strong presence of pharmaceutical, biotechnology, and research institutions. Increasing demand for high-throughput testing, greater laboratory efficiency, and reproducible sample processing is further supporting the adoption of automated liquid handling systems.
The United States automated liquid handling market is expected to benefit from a growing older population and associated healthcare and research needs, with the U.S. Census Bureau projecting that one in five Americans will be aged 65 or older by 2030, while older adults are projected to outnumber children by 2034, supporting continued demand for high-throughput laboratory testing and automated sample processing.
The Canada automated liquid handling market is expected to benefit from rising healthcare and laboratory demand associated with population aging, with Statistics Canada projecting the share of people aged 65 and older to increase from 19.5% in 2025 to 22.6%–32.5% by 2075, while the population aged 85 and older is projected to rise from 951,833 in 2025 to 3.3–4.2 million by 2075.
Unlock Regional Insightsto access country-level data, & regional trends.
The European automated liquid handling market is expected to grow at a CAGR of 12.24% during the forecast period, making it the fastest-growing regional market, driven by increasing laboratory automation, rising demand for high-throughput testing, and growing adoption of automated workflows across pharmaceutical, biotechnology, and academic research laboratories. The U.K. automated liquid handling market is expected to benefit from expanding life sciences investment, with the U.K. Government targeting more commercial life-sciences R&D investment than any other European economy by 2030, supporting greater demand for advanced laboratory automation and high-throughput research technologies.
The German automated liquid handling market is expected to benefit from continued growth in biopharmaceutical research, with Germany’s biopharmaceutical clinical-development pipeline increasing from 657 programs in 2020 to 674 in 2024, while pharmaceutical companies invested €10.7 billion in R&D in 2024, supporting future demand for automated laboratory workflows. The France automated liquid handling market is expected to benefit from expanding biomedical research and bioproduction, with France’s France 2030 program allocating €7.5 billion to Innovation Santé 2030 and targeting the development and production of advanced biotherapies and biomedicines through 2030, supporting demand for automated laboratory and liquid-handling technologies.
The automated liquid handling market is moderately fragmented, with a mix of multinational laboratory automation companies, life-science instrument manufacturers, robotics providers, and specialized automation technology firms serving pharmaceutical, biotechnology, clinical, and research laboratories. Key players such as Thermo Fisher Scientific, Danaher, Agilent Technologies, Hamilton Company, Tecan Group, and PerkinElmer are collectively estimated to account for approximately 50% of the global automated liquid handling market share.
Established players compete primarily on automation capabilities, system reliability, precision, throughput, workflow integration, broad product portfolios, global service networks, and compatibility with laboratory equipment and software. Emerging and specialized players in the automated liquid handling market ecosystem compete through flexible platforms, modular systems, application-specific automation, advanced software, AI-enabled workflow optimization, and cost-effective solutions that address the needs of smaller laboratories and specialized workflows. The competitive environment is shaped by accuracy, reproducibility, scalability, ease of integration, customization, and the ability to automate increasingly complex laboratory processes.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Head
Ismail Sutaria is a market intelligence and strategy professional with over 12 years of experience advising organizations across the chemicals, packaging, industrial machinery, and energy & power sectors. He specializes in delivering data-driven market assessments, commercial due diligence, industry benchmarking, demand forecasting, competitive strategy, and growth advisory that enable businesses to make confident investment and expansion decisions in complex industrial markets.
His expertise spans specialty and commodity chemicals, advanced and sustainable packaging solutions, industrial automation, manufacturing equipment, process engineering, renewable energy, conventional power generation, electrical infrastructure, and industrial technologies. Ismail has developed deep domain knowledge in evaluating market ecosystems, technology evolution, regulatory frameworks, supply-demand dynamics, pricing trends, value chain structures, and competitive landscapes across global and regional markets.
Cleaning Robot Market Size, Share, Growth, Analysis, Report, 2034
Linear Motion System Market Size, Share, Growth, Analysis, 2034
Arc Welding Robots Market Size, Share, Growth, Analysis, 2034
Collaborative Robots Market Size, Share, Growth, Analysis, 2034
Line Scan Camera Market Size, Share, Growth, Analysis, 2034
Area Scan Camera Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com